Friday, May 11, 2007

Barr Pharmaceuticals gets tentative OK for generic dementia drug

(Reuters) - The product had annual sales of about $140 million for the 12 months ended March 2007, according to IMS sales data. Janssen Pharmaceutica is a unit of Johnson & Johnson




Read more at Reuters.com Government Filings News

No comments: